Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease (ItinerAir)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02260362|
Recruitment Status : Recruiting
First Posted : October 9, 2014
Last Update Posted : November 24, 2017
The complex congenital cardiac malformations are a significant number of different diseases, each having specific natural histories. The interface with pulmonary arterial hypertension (HTAP) is high since the physiology of many of these disorders comprises alterations in pulmonary vasculature.
This observatory is a cohort of 400 patients enrolled in 3 years, older than one month, having been informed and have agreed to participate in the study and with congenital heart disease other than patent foramen ovale as well as a diagnosis of pulmonary hypertension confirmed by cardiac catheterization.
The main objectives of this report are to know
- Incidence of congenital heart disease in HTAP France.
- Describe the natural history of HTAP in a large population of patients Congenital heart disease in France
- The characteristics of HTAP congenital heart disease
- Having a cohort study
|Condition or disease|
|Pulmonary Arterial Hypertension of Congenital Heart Disease|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||November 2018|
|Estimated Study Completion Date :||December 2021|
|HTAP of Congenital Heart Disease|
- Incidence HTAP of congenital heart disease in France. [ Time Frame: 3 years ]Number of HTAP of congenital heart disease in France after 3 years of inclusions
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02260362
|Contact: Damien Bonnet||33(0)email@example.com|
|Hopital Necker Enfants Malades||Recruiting|
|Contact: Damien Bonnet|